News Release

Patently harmful: Fewer female inventors a problem for women's health

Female inventors hold just a quarter of US biomedical patents

Peer-Reviewed Publication

McGill University

Necessity is the father of invention, but where is its mother? According to a new study published in Science, fewer women hold biomedical patents, leading to a reduced number of patented technologies designed to address problems affecting women.

While there are well-known biases that limit the number of women in science and technology, the consequences extend beyond the gender gap in the labour market, say researchers from McGill University, Harvard Business School, and the Universidad de Navarra in Barcelona. Demographic inequities in who gets to invent lead to demographic inequities in who benefits from invention.

"Although the percentage of biomedical patents held by women has risen from 6.3% to 16.2% over the last three decades, men continue to significantly outnumber women as patent holders. As a result, health inventions have tended to focus more on the needs of men than women," says co-author John-Paul Ferguson, an Associate Professor in the Desautels Faculty of Management at McGill University.

The inventor gender gap

To determine which inventions are female-focused, male-focused, or neutral, researchers analyzed 441,504 medical patents filed from 1976 through 2010 using machine learning. They show that patented biomedical inventions created by women are up to 35% more likely to benefit women's health than biomedical inventions created by men. These patents are more likely to address conditions like breast cancer and postpartum preeclampsia, as well as diseases that disproportionately affect women, like fibromyalgia and lupus.

While inventions by women are more likely to be female-focused, such patents have been less common because so few inventors were women. In total, women were listed as co-inventors on just a quarter of all patents filed during the period.

The researchers note that female scientists are 40% less likely to commercialize their research ideas than male scientists. The causes of this gender gap are myriad, from differences in mentoring to biases in the early-stage feedback that women receive when trying to commercialize female-focused ideas.

"Our findings suggest that the inventor gender gap is partially responsible for thousands of missing female-focused inventions since 1976. Our calculations suggest that had male and female inventors been equally represented over this period, there would have been an additional 6,500 more female-focused inventions," says say co-author Rembrand Koning, an Assistant Professor at Harvard Business School.

Gender bias in biomedical innovation

The results reveal that inventions by research teams primarily or completely composed of men are more likely to focus on the medical needs of men. In 34 of the 35 years from 1976 to 2010, male-majority teams produced hundreds more inventions focused on the needs of men than those focused on the needs of women.

Male inventors also tended to target diseases and conditions like Parkinson's and sleep apnea, which disproportionately affect men. Overall, the researchers found that across inventor teams of all gender mixes, biomedical invention from 1976 to 2010 focused more on the needs of men than women.

Benefits of more women inventing

The researchers also found more subtle benefits when more women invent. Female inventors are more likely to identify how existing treatments for non-sex-specific diseases like heart attacks, diabetes, and stroke can be improved and adapted for the needs of women. They are also more likely to test whether their ideas and inventions affect men and women differently: for example, if a drug has more adverse side effects in women than in men.

"Our results suggest that increasing representation should address these invisible biases," says Koning.


About this study

"Who do we invent for? Patents by women focus more on women's health, but few women get to invent" by Rembrand Koning, Sampsa Samila, and John-Paul Ferguson was published in Science.


About McGill University

Founded in Montreal, Quebec, in 1821, McGill University is Canada's top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It'is a world-renowned institution of higher learning with research activities spanning two campuses, 11 faculties, 13 professional schools, 300 programs of study and over 40,000 students, including more than 10,200 graduate students. McGill attracts students from over 150 countries around the world, its 12,800 international students making up 31% of the student body. Over half of McGill students claim a first language other than English, including approximately 19% of our students who say French is their mother tongue.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.